Abstract
Sepsis is a common, life-threatening complication of infection with gram-negative bacteria. While the pathophysiology of gram-negative sepsis has not been fully elucidated, a significant portion of the clinical syndrome can probably be attributed to the activation by endotoxin of a cascade of secondary mediators. These mediators initiate a series of complicated events, including systemic response to infection (fever or hypothermia, tachycardia, tachypnea) and dysfunction or failure of critical organ systems including the kidney, lung, brain, liver, and cardiovascular and coagulation systems [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bone RC, Fisher LT, Clemmer TP et al. (1989) Sepsis syndrome: a valid clinical entity. Crit Care Med 17:389–393
Lüderitz O, Tanamoto K, Galanos C et al. (1984) Lipopolysaccharides: structural principles and biologic activities. Rev Infect Dis 6:428–431
Andersson JF, Melchers C, Galancos C et al. (1973) The mitogenic effects of lipopolysaccharide on bone marrow derived mouse lymphocytes. J Exp Med 39:943–950
Galanos C, Lüderitz O, Rietschel ET et al. (1985) Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem 148:1–5
McCabe WR, Kreger BE, Johns M (1972) Type-specific and cross-reactive anti-bodies in Gram-negative bacteremia. N Engl J Med 287:261–267
Ziegler EJ, McCutchan JA, Fierer J et al. (1982) Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307:1225–1230
Calandra T, Glauser MP, Schellekens J et al. (1988) Treatment of Gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. J Infect Dis 158:312–319
Young LS (1984) Functional activity of monoclonal antibodies against lipopolysaccharide (LPS) antigens of Gram negative bacilli. Clin Res (abstract) 32/2:518A
Stoll BJ, Pollack M, Young LS et al. (1986) Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide. Infect Immun 53:656–662
Evans ME, Pollack M, Hardegen NJ et al. (1990) Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to Gram-negative bacteria. J Infect Dis 162:148–155
Wood D, Parent JB, Gazzano-Santoro H (1992) Reactivity of monoclonal antibody E5® with endotoxin. I. Binding to lipid A and rough lipopolysaccharides. Circ Shock (in press)
Parent JB et al. (1992) Reactivity of monoclonal antibody E5® with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides. Circ Shock (in press)
Young LS, Gascon R, Alam S et al. (1989) Monoclonal antibodies for treatment of Gram-negative infections. Rev Infect Dis 11/Suppl 7:S1564–S1571
Gorelick K, Scannon PJ, Hannigan J et al. (1990) Randomized placebo-controlled study of E5 monoclonal antiendotoxin antibody. In: Larrick JW, Borrebaeck CK (eds) Therapeutic monoclonal antibodies. Stockton, New York, pp 253–261
MacIntyre NR, Schein RM, Hannigan JF et al. (1990) E5 antibody enhances resolution of multi-organ failure in Gram-negative sepsis. Chest (abstract) 98/2 Suppl:135S
MacIntyre NR, Emmanuel G, Wedel NI et al. (1991) E5 antibody improves outcome from multi-organ failure in survivors of Gram-negative sepsis. Crit Care Med (abstract) 19/4 Suppl:S14
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag, Berlin Heidelberg
About this chapter
Cite this chapter
Gorelick, K.J. et al. (1993). Binding Characteristics of the Antiendotoxin Antibody Xomen-E5 to Bacterial Whole-Cell Antigens. In: Faist, E., Meakins, J.L., Schildberg, F.W. (eds) Host Defense Dysfunction in Trauma, Shock and Sepsis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77405-8_156
Download citation
DOI: https://doi.org/10.1007/978-3-642-77405-8_156
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77407-2
Online ISBN: 978-3-642-77405-8
eBook Packages: Springer Book Archive